227 related articles for article (PubMed ID: 26440750)
21. Simian immunodeficiency virus and human immunodeficiency virus type 1 nef proteins show distinct patterns and mechanisms of Src kinase activation.
Greenway AL; Dutartre H; Allen K; McPhee DA; Olive D; Collette Y
J Virol; 1999 Jul; 73(7):6152-8. PubMed ID: 10364375
[TBL] [Abstract][Full Text] [Related]
22. Crystal structure of the Src family kinase Hck SH3-SH2 linker regulatory region supports an SH3-dominant activation mechanism.
Alvarado JJ; Betts L; Moroco JA; Smithgall TE; Yeh JI
J Biol Chem; 2010 Nov; 285(46):35455-61. PubMed ID: 20810664
[TBL] [Abstract][Full Text] [Related]
23. SH3-dependent stimulation of Src-family kinase autophosphorylation without tail release from the SH2 domain in vivo.
Lerner EC; Smithgall TE
Nat Struct Biol; 2002 May; 9(5):365-9. PubMed ID: 11976726
[TBL] [Abstract][Full Text] [Related]
24. SH3 domains with high affinity and engineered ligand specificities targeted to HIV-1 Nef.
Hiipakka M; Poikonen K; Saksela K
J Mol Biol; 1999 Nov; 293(5):1097-106. PubMed ID: 10547288
[TBL] [Abstract][Full Text] [Related]
25. Competitive displacement of full-length HIV-1 Nef from the Hck SH3 domain by a high-affinity artificial peptide.
Stangler T; Tran T; Hoffmann S; Schmidt H; Jonas E; Willbold D
Biol Chem; 2007 Jun; 388(6):611-5. PubMed ID: 17552908
[TBL] [Abstract][Full Text] [Related]
26. Hck SH3 domain-dependent abrogation of Nef-induced class 1 MHC down-regulation.
Chang AH; O'Shaughnessy MV; Jirik FR
Eur J Immunol; 2001 Aug; 31(8):2382-7. PubMed ID: 11500821
[TBL] [Abstract][Full Text] [Related]
27. HIV-1 Nef perturbs the function, structure, and signaling of the Golgi through the Src kinase Hck.
Hiyoshi M; Takahashi-Makise N; Yoshidomi Y; Chutiwitoonchai N; Chihara T; Okada M; Nakamura N; Okada S; Suzu S
J Cell Physiol; 2012 Mar; 227(3):1090-7. PubMed ID: 21567396
[TBL] [Abstract][Full Text] [Related]
28. Interaction between Hck and HIV-1 Nef negatively regulates cell surface expression of M-CSF receptor.
Hiyoshi M; Suzu S; Yoshidomi Y; Hassan R; Harada H; Sakashita N; Akari H; Motoyoshi K; Okada S
Blood; 2008 Jan; 111(1):243-50. PubMed ID: 17893228
[TBL] [Abstract][Full Text] [Related]
29. HIV-1 Nef selectively activates Src family kinases Hck, Lyn, and c-Src through direct SH3 domain interaction.
Trible RP; Emert-Sedlak L; Smithgall TE
J Biol Chem; 2006 Sep; 281(37):27029-38. PubMed ID: 16849330
[TBL] [Abstract][Full Text] [Related]
30. Identification of Hck inhibitors as hits for the development of antileukemia and anti-HIV agents.
Tintori C; Laurenzana I; La Rocca F; Falchi F; Carraro F; Ruiz A; Esté JA; Kissova M; Crespan E; Maga G; Biava M; Brullo C; Schenone S; Botta M
ChemMedChem; 2013 Aug; 8(8):1353-60. PubMed ID: 23813855
[TBL] [Abstract][Full Text] [Related]
31. The accessory factor Nef links HIV-1 to Tec/Btk kinases in an Src homology 3 domain-dependent manner.
Tarafdar S; Poe JA; Smithgall TE
J Biol Chem; 2014 May; 289(22):15718-28. PubMed ID: 24722985
[TBL] [Abstract][Full Text] [Related]
32. Evolutionary plasticity of SH3 domain binding by Nef proteins of the HIV-1/SIVcpz lentiviral lineage.
Zhao Z; Fagerlund R; Tossavainen H; Hopfensperger K; Lotke R; Srinivasachar Badarinarayan S; Kirchhoff F; Permi P; Sato K; Sauter D; Saksela K
PLoS Pathog; 2021 Nov; 17(11):e1009728. PubMed ID: 34780577
[TBL] [Abstract][Full Text] [Related]
33. Activation of the Src family kinase Hck without SH3-linker release.
Lerner EC; Trible RP; Schiavone AP; Hochrein JM; Engen JR; Smithgall TE
J Biol Chem; 2005 Dec; 280(49):40832-7. PubMed ID: 16210316
[TBL] [Abstract][Full Text] [Related]
34. Single-domain antibody-SH3 fusions for efficient neutralization of HIV-1 Nef functions.
Bouchet J; Hérate C; Guenzel CA; Vérollet C; Järviluoma A; Mazzolini J; Rafie S; Chames P; Baty D; Saksela K; Niedergang F; Maridonneau-Parini I; Benichou S
J Virol; 2012 May; 86(9):4856-67. PubMed ID: 22345475
[TBL] [Abstract][Full Text] [Related]
35. Structure, function, and inhibitor targeting of HIV-1 Nef-effector kinase complexes.
Staudt RP; Alvarado JJ; Emert-Sedlak LA; Shi H; Shu ST; Wales TE; Engen JR; Smithgall TE
J Biol Chem; 2020 Oct; 295(44):15158-15171. PubMed ID: 32862141
[TBL] [Abstract][Full Text] [Related]
36. A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein.
Lee CH; Leung B; Lemmon MA; Zheng J; Cowburn D; Kuriyan J; Saksela K
EMBO J; 1995 Oct; 14(20):5006-15. PubMed ID: 7588629
[TBL] [Abstract][Full Text] [Related]
37. Effect of the SH3-SH2 domain linker sequence on the structure of Hck kinase.
Meiselbach H; Sticht H
J Mol Model; 2011 Aug; 17(8):1927-34. PubMed ID: 21110053
[TBL] [Abstract][Full Text] [Related]
38. HIV-1 Nef Induces Hck/Lyn-Dependent Expansion of Myeloid-Derived Suppressor Cells Associated with Elevated Interleukin-17/G-CSF Levels.
Priceputu E; Cool M; Bouchard N; Caceres-Cortes JR; Lowell CA; Hanna Z; Jolicoeur P
J Virol; 2021 Aug; 95(17):e0047121. PubMed ID: 34106001
[TBL] [Abstract][Full Text] [Related]
39. RT loop flexibility enhances the specificity of Src family SH3 domains for HIV-1 Nef.
Arold S; O'Brien R; Franken P; Strub MP; Hoh F; Dumas C; Ladbury JE
Biochemistry; 1998 Oct; 37(42):14683-91. PubMed ID: 9778343
[TBL] [Abstract][Full Text] [Related]
40. Hck inhibitors as potential therapeutic agents in cancer and HIV infection.
Musumeci F; Schenone S; Brullo C; Desogus A; Botta L; Tintori C
Curr Med Chem; 2015; 22(13):1540-64. PubMed ID: 25666803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
